American Heart News - Heart News
JANUARY 31, 2024
DALLAS, Feb. 1, 2024 – From news desks to iconic buildings, scores of people and landmarks across the U.S. will once again “go red” on National Wear Red Day, Feb. 2, to raise awareness that cardiovascular disease is the No. 1 killer of women and support.
Science Daily - Heart Disease
JANUARY 31, 2024
Radon is the second leading cause of lung cancer. Now a new study has found exposure to this invisible, odorless gas is also linked to an increased risk of stroke. The study, which examined exposures in middle age to older female participants, found an increased risk of stroke among those exposed to high and even moderate concentrations of the gas compared to those exposed to the lowest concentrations.
DAIC
JANUARY 31, 2024
milla1cf Wed, 01/31/2024 - 17:10 January 31, 2024 — Royal Philips , a global leader in health technology, announced that its latest TEE transducer, designed to serve more patients with improved overall comfort, has received FDA 510(k) clearance. Cardiovascular ultrasound has played a key role in the evolution of early diagnosis of structural heart disease, led by a technology pioneered by Philips: the ‘transesophageal echocardiography’ (TEE) ultrasound transducer.
HCPLive
JANUARY 31, 2024
Of the 135 laser flare photometry readings to identify uveitis among patients with juvenile idiopathic arthritis, only 3% were characterized as a false positive.
DAIC
JANUARY 31, 2024
The U.S. Food and Drug Administration (FDA), has granted approval to Boston Scientific for its FARAPULSE Pulsed Field Ablation System. A company statement reported that its PFA System is indicated for the isolation of pulmonary veins in the treatment of drug-refractory, recurrent, symptomatic, paroxysmal (i.e., intermittent) atrial fibrillation (AF) and is a unique new alternative to standard-of-care thermal ablation treatment.
Frontiers in Cardiovascular Medicine
JANUARY 31, 2024
Background The aim of this study was to identify significant factors affecting the effectiveness of exercise training using information of the HF-ACTION (Heart Failure: A Controlled Trial Investigating Outcomes of Exercise Training) study. Methods Background factors influencing the effect of exercise training were comprehensively surveyed for 2,130 patients by multivariable Cox regression analysis with the stepwise variable selection, and only significant factors were selected that were statisti
DAIC
JANUARY 31, 2024
GORE VIABAHN VBX Balloon Expandable Endoprosthesis milla1cf Wed, 01/31/2024 - 17:04 January 31, 2024 — As part of efforts to continuously improve medical solutions for patients with complex vascular disease, W. L. Gore & Associates, Inc. (Gore) announced recent FDA approval of a lower profile GORE VIABAHN VBX Balloon Expandable Endoprosthesis ( VBX Stent Graft ).
Cardiovascular Update brings together the best content for cardiovascular medicine professionals from the widest variety of industry thought leaders.
DAIC
JANUARY 31, 2024
Getty Images milla1cf Wed, 01/31/2024 - 17:07 January 31, 2024 — Coronary artery calcification is increasing in prevalence, leading to greater risks both during procedures such as percutaneous coronary intervention (PCI) and adverse events in the short and long term. Along with these challenges, treatment options are expanding, increasingly including calcium modification prior to stent implantation.
Dr. Smith's ECG Blog
JANUARY 31, 2024
A 60-something male presented stating that he had had chest pain that morning which awoke him from sleep but then resolved after several minutes. He has had similar pain in the past which he attributed to acid reflux. He has a history of untreated hypertension. He is pain free now. His systolic BP was 200. The patient is pain free at the time of this ECG: What do you think?
HCPLive
JANUARY 31, 2024
Low eGFRcr-cys was more strongly and uniformly associated with adverse outcomes compared to low eGFRcr in an older patient population, highlighting the benefit of including cystatin C in GFR estimation.
Cardiovascular Diabetology
JANUARY 31, 2024
Diabetes mellitus is a chronic disease which is detrimental to cardiovascular health, often leading to secondary microvascular complications, with huge global health implications. Therapeutic interventions tha.
HCPLive
JANUARY 31, 2024
In a study comparing readmission rates for patients with schizophrenia or schizoaffective disorder on oral or long-acting injections, investigators found after 30 days the readmission rate was 8.3% among patients who received pills and 1.9% among patients who received injections.
Medical Xpress - Cardiology
JANUARY 31, 2024
Replacement heart valves that grow inside the body are a step closer to reality following studies led by researchers at Imperial. The results are published in Communications Biology.
HCPLive
JANUARY 31, 2024
A recent analysis found risk factors linked to an embolism after VTE included Black race, interstitial fibrosis, advanced-stage disease, and increased operative duration.
Med Page Today
JANUARY 31, 2024
(MedPage Today) -- The FDA approved the Farapulse pulsed field ablation (PFA) system for paroxysmal atrial fibrillation (Afib or AF), Boston Scientific announced on Wednesday. The device won an indication for the isolation of pulmonary veins in.
American Heart News - Heart News
JANUARY 31, 2024
Research Highlights: An analysis of cardiac arrest records in a U.S. registry revealed that people with drug overdose cardiac arrests were more likely to be younger, have fewer health conditions and have higher survival rates with better neurologic.
Med Page Today
JANUARY 31, 2024
(MedPage Today) -- SAN ANTONIO -- Researchers made a case for superior long-term survival with multi-arterial grafts (MAGs) during multivessel coronary artery bypass grafting (CABG) surgery, with some arguing that this should be more widely adopted.
Medical Xpress - Cardiology
JANUARY 31, 2024
Researchers from the Johns Hopkins Bloomberg School of Public Health have developed a single universal risk prediction model for cardiovascular disease that, in initial tests, works well for patients who already have cardiovascular disease as well as patients who do not but who may be at risk for developing it. Clinicians currently use two separate risk models to assess patients' chances of having heart attacks, strokes, and other major cardiovascular events.
Journal of the American Heart Association
JANUARY 31, 2024
Journal of the American Heart Association, Ahead of Print. BackgroundGiven increases in drug overdose‐associated mortality, there is interest in better understanding of drug overdose out‐of‐hospital cardiac arrest (OHCA). A comparison between overdose‐attributable OHCA and nonoverdose‐attributable OHCA will inform public health measures.Methods and ResultsWe analyzed data from 2017 to 2021 in the Cardiac Arrest Registry to Enhance Survival (CARES), comparing overdose‐attributable OHCA (OD‐OHCA)
Medical Xpress - Cardiology
JANUARY 31, 2024
A collaborative cohort of researchers, led by University of Colorado Anschutz Medical Campus professor Angelo D'Alessandro, has identified kynurenine as a critical new biomarker in the quality of stored red blood cells (RBCs), a crucial step in the development of more personalized transfusions. The study results appear in the journal Blood.
The New England Journal of Medicine
JANUARY 31, 2024
This review highlights new developments in cardiac implantable electronic devices, with an emphasis on pacemakers, newer modes of pacing, and implantable cardioverter–defibrillators.
Journal of the American Heart Association
JANUARY 31, 2024
Journal of the American Heart Association, Ahead of Print. BackgroundEffective therapies for reducing cardiovascular disease (CVD) risk in people with elevated lipoprotein(a) are lacking, especially for primary prevention. Because of the potential association of lipoprotein(a) with thrombosis, we evaluated the relationship between aspirin use and CVD events in people with elevated lipoprotein(a).Methods and ResultsWe used data from the MESA (Multi‐Ethnic Study of Atherosclerosis), a prospective
HCPLive
JANUARY 31, 2024
In this feature, we acknowledge the impact of the 1964 Surgeon General report, its subsequent effect on public health, and present-day hurdles to optimized public health efforts through the eyes of our editorial advisory board members and other leading experts.
Medical Xpress - Cardiology
JANUARY 31, 2024
Changes to blood pressure over time could be used to identify patients at greatest risk of heart attack and stroke. These are the findings of a new analysis from the ASCOT study, led by researchers from Imperial College London and published in the European Heart Journal.
The New England Journal of Medicine
JANUARY 31, 2024
A 66-year-old man was transferred to a hospital after a cardiac arrest. Coronary angiography (shown in a video) revealed 50% stenosis in the middle LAD coronary artery during diastole with complete occlusion during systole.
Medical Xpress - Cardiology
JANUARY 31, 2024
Coronary artery calcification is increasing in prevalence, leading to greater risks both during procedures such as percutaneous coronary intervention (PCI) and adverse events in the short and long term. Along with these challenges, treatment options are expanding, increasingly including calcium modification prior to stent implantation.
CardiacWire
JANUARY 31, 2024
Procedure trends certainly suggest that we’ve entered the TAVR era, but a pair of new studies show that surgical aortic valve replacement (SAVR) is a far better option for many younger and healthier patients who are increasingly seen as TAVR candidates. In the first study presented at The Society of Thoracic Surgeons’ 2024 Annual Meeting , researchers analyzed outcomes from 37k California-based patients who underwent SAVR or TAVR between 2013 to 2021… Of the 2,360 patients under the age of
Becker's Hospital Review - Cardiology
JANUARY 31, 2024
Weill Cornell Medicine and NewYork-Presbyterian Komansky Children's Hospital, both based in New York City, appointed Bernhard Kühn, MD, chief of the division of cardiology in the department of pediatrics.
American College of Cardiology
JANUARY 31, 2024
Does high-sensitivity C-reactive protein (hsCRP) modulate the association between lipoprotein(a) [Lp(a)] and coronary heart disease (CHD) in the general population when defined as prevalent and incident events?
Frontiers in Cardiovascular Medicine
JANUARY 31, 2024
Objective In patients with complex coronary artery disease (CAD) undergoing cardiac surgery, myocardial protection might be impaired due to microvascular obstruction, resulting in myocardial injury and subsequent biomarker release. Therefore, this study investigated the correlation between the complexity of CAD, reflected by the SYNTAX Score, and the release of cardiac biomarkers after CABG.
Becker's Hospital Review - Cardiology
JANUARY 31, 2024
FDA approves Boston Scientific's FaraPulse system for treating atrial fibrillation, using non-thermal electric pulses to safely remove heart tissue.
Frontiers in Cardiovascular Medicine
JANUARY 31, 2024
Objectives The purpose of this study was to assess the clinical outcome after right ventricular outflow tract (RVOT) stenting in late presenter patient with unrepaired Fallot physiology. Background In younger patients, RVOT stenting is an alternative to mBTT shunt; however, there have been few reports of this palliative technique in late presenter population, including adults.
Medical Xpress - Cardiology
JANUARY 31, 2024
An analysis of data for more than 500,000 out-of-hospital cardiac arrests in the U.S. found key differences in outcomes between cardiac arrests caused by drug overdoses and cardiac arrests due to other causes, according to new research published today in the Journal of the American Heart Association.
Frontiers in Cardiovascular Medicine
JANUARY 31, 2024
Introduction We conducted a study to determine the prevalence of structural heart disease in patients with CF, the characteristics of a cardiomyopathy not previously described in this population, and its possible relationship with nutritional deficiencies in CF. Methods We studied 3 CMP CF patients referred for heart-lung transplantation and a prospective series of 120 adult CF patients.
American College of Cardiology
JANUARY 31, 2024
Can a universal risk prediction model be developed for persons with and without atherosclerotic cardiovascular disease (ASCVD)?
Frontiers in Cardiovascular Medicine
JANUARY 31, 2024
Background Estrogen and progesterone levels undergo changes throughout the menstrual cycle. Existing literature regarding the effect of menstrual phases on cardiovascular and autonomic regulation during central hypovolemia is contradictory. Aims and study This study aims to explore the influence of menstrual phases on cardiovascular and autonomic responses in both resting and during the central hypovolemia induced by lower body negative pressure (LBNP).
American College of Cardiology
JANUARY 31, 2024
The U.S. Food and Drug Administration (FDA) has approved the FARAPULSE Pulsed Field Ablation System for isolation of pulmonary veins in the treatment of drug-refractory, recurrent, symptomatic, paroxysmal atrial fibrillation (AFib), according to a Boston Scientific press release.
Expert insights. Personalized for you.
144 
Let's personalize your content